Latest filing published 04 Aug 2026 for COSCIENS Biopharma Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Robert Andrew Seager discloses dealings in COSCIENS Biopharma Inc. to SEDI. Between 30 May 2025 and 4 August 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 4 August 2026, reports a share grant in COSCIENS Biopharma Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations